Moxifloxacin impurity 126 CAS CATO-C4X-1074126
| CAS No. | CATO-C4X-1074126 |
| Molecular Formula | C7H13N3O |
| Molecular Weight | 155.20 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
Under current pharmacopoeial and regulatory frameworks, quality-control requirements for this class of reference material explicitly involve the control of targets including Moxifloxacin impurity 126.
As a process- or degradation-related impurity, Moxifloxacin impurity 126 (CAS CATO-C4X-1074126, C7H13N3O) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.
Moxifloxacin impurity 126 (C7H13N3O) contains an amide group, a hydroxyl group, an ether linkage. Its physicochemical properties are representative of its class; these physicochemical properties determine the optimal preparation and storage of its standard solutions. Nitrogen-containing functional groups confer excellent ionization efficiency in positive-ion electrospray (ESI) mode, making the compound well suited to LC-MS/MS analysis.
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
As a certified reference material (CRM), Moxifloxacin impurity 126 meets the metrological traceability requirements of ISO/IEC 17025 laboratories. Batch-to-batch consistency is monitored via control charts to guarantee comparable assigned values across lots.
Physical & Chemical Properties
| Molecular Formula | C7H13N3O |
| Molecular Weight | 155.20 g/mol |
| Appearance | White to pale yellow crystalline powder. (faint amine-like odor) |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | Light-sensitive; avoid direct strong light |
| Degree of Unsaturation (DBE) | 3.0 |
| UV Absorption | UV-absorbing |
| Nitrogen Atoms | 3 |
Related Moxifloxacin Standards
- Moxifloxacin impurity 127 (CAS CATO-C4X-1074127)
- Moxifloxacin impurity 172 (CAS CATO-C4X-1074172)
- Moxifloxacin Impurity 152 (CAS 1932592-78-3)
- Moxifloxacin Imp.X (CAS 4664-00-0)
- Moxifloxacin Impurity 91 (CAS 89-00-9)
- Moxifloxacin Impurity 89 (CAS 924-99-2)
- Moxifloxacin Impurity 27 (CAS 128740-18-1)
- Moxifloxacin impurity 180 (CAS 151213-45-5)
Recommended Standards
- 95-23-8 3V3FDT3X0M 5-Amino-2-hydroxybenzimidazole 5-Amino-1,3-dihydro-2H-benzimidazol-2-one 2H-Benzimidazol-2-one, 5-amino-1,3-dihydro- EINECS 202-401-8 EC 202-401-8 UNII-3V3FDT3X0M (CAS 95-23-8)
- 938459-04-2 N-[(3-Ethyl-1,2,4-oxadiazol-5-yl)methyl]ethanamine DTXSID10650858 (CAS 938459-04-2)
- 915923-58-9 [2-(3-isopropyl-1,2,4-oxadiazol-5-yl)ethyl]amine hydrochloride (CAS 915923-58-9)
- N-Nitroso-Moxifloxacin impurity 173 (CAS CATO-C4X-1074173)
- Acalabrutinib Impurity 10 (CAS CATO-C4X-305510)
- Tramadol Impurity 17 (CAS CATO-C4X-149817)
- Levocabastine impurity 24 (CAS CATO-C4X-228924)
- Cyclohexaneacetic acid,4-[4-(4-amino-7,7-dimethyl-7H-pyrimido[4,5-b][1,4]oxazin-6-yl)phenyl]-,trans- (CAS 701234-65-3)
- 2-((3-Methylbenzyl)thio)aniline hydrochloride (CAS 1049745-27-8)
- 4-Methyl-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-7-boronic Acid (CAS 1515875-37-2)
- 6-[2-(2-methylthiazol-4-yl)ethynyl]-1,2-benzoxazol-3-amine (CAS 2495699-43-7)
- 1,2,3,4-Tetrahydroisoquinoline-8-carbonitrile hydrochloride (CAS 1203682-31-8)
- Fmoc-D-Thr(tBu)-Phe-OH (CAS CATO-CPTD788778)
- Semaglutide impurity 80 (CAS CATO-C4X-222680)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com